CytRx said this week that it has appointed Matthew Natalizio as the company’s chief financial officer.
In August last year, CytRx named Kirk Peacock as its CFO, but a CytRx spokeswoman told RNAi News that Peacock resigned effective June 15. Peacock continues to serve as a consultant to the company in order to assist in the transition to the new CFO, she added.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
